We did not find any significant relation among IL-6, membrane IL-6R levels, GLA mutation status, age, gender, FD specific (ERT or chaperonic) and other therapies, kidney disease biomarkers, levels of lyso-Gb3, and the presence of a classical or a late form of FD. This evidence concerns the gene IL6R and Fabry disease.